NYSEArca - Delayed Quote USD

WisdomTree U.S. ESG Fund (RESP)

50.79 +0.12 (+0.24%)
At close: January 26 at 2:36 PM EST
Loading Chart for RESP
DELL
  • Previous Close 50.67
  • Open 50.92
  • Bid --
  • Ask --
  • Day's Range 50.65 - 50.94
  • 52 Week Range 42.22 - 50.94
  • Volume 18,661
  • Avg. Volume 4,072
  • Net Assets 66M
  • NAV 50.77
  • PE Ratio (TTM) 20.77
  • Yield 1.33%
  • YTD Daily Total Return 3.26%
  • Beta (5Y Monthly) 0.97
  • Expense Ratio (net) 0.28%

The fund is actively managed using a model-based approach and seeks to achieve its investment objective by investing primarily in U.S. equity securities of companies that exhibit the highest potential for returns based on proprietary measures of fundamental factors and technical factors, as well as favorable environmental, social, and governance (“ESG”) characteristics. The adviser primarily uses a proprietary multi-factor model to select the fund’s investments. The fund is non-diversified.

WisdomTree

Fund Family

Large Blend

Fund Category

66M

Net Assets

2007-02-23

Inception Date

Performance Overview: RESP

Trailing returns as of 2/15/2024. Category is Large Blend.

YTD Return

RESP
3.26%
Category
9.95%
 

1-Year Return

RESP
16.64%
Category
27.24%
 

3-Year Return

RESP
7.01%
Category
9.88%
 

People Also Watch

Holdings: RESP

Top 10 Holdings (27.79% of Total Assets)

SymbolCompany% Assets
AAPL
Apple Inc. 6.29%
MSFT
Microsoft Corporation 6.03%
GOOGL
Alphabet Inc. 3.82%
NVDA
NVIDIA Corporation 2.80%
AMZN
Amazon.com, Inc. 2.76%
META
Meta Platforms, Inc. 2.02%
BRK-B
Berkshire Hathaway Inc. 1.18%
V
Visa Inc. 1.03%
JPM
JPMorgan Chase & Co. 0.95%
LLY
Eli Lilly and Company 0.90%

Sector Weightings

SectorRESP
Technology   30.90%
Healthcare   13.16%
Industrials   9.03%
Real Estate   2.65%
Utilities   2.31%
Energy   0.00%

Related ETF News

Research Reports: RESP

  • RMD: Raising target price to $157.00

    RESMED INC has an Investment Rating of SELL; a target price of $157.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Bearish
    Price Target
     
  • RMD: Raising target price to $153.00

    RESMED INC has an Investment Rating of SELL; a target price of $153.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Bearish
    Price Target
     
  • RMD: Raising target price to $142.00

    RESMED INC has an Investment Rating of SELL; a target price of $142.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Bearish
    Price Target
     
  • HAE: Lowering target price to $89.00

    HAEMONETICS CORP/MASS has an Investment Rating of HOLD; a target price of $89.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Neutral
    Price Target
     

Related Tickers